z-logo
Premium
Erythrocyte (RBC)‐Released ATP and Vascular Control: When it Works and What if it Does Not?
Author(s) -
Ellis Christopher G.,
Goldman Daniel,
Sprague Randy S.,
Ford David A.,
Stephenson Alan H.,
Ellsworth Mary L.
Publication year - 2009
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.23.1_supplement.948.5
Subject(s) - microcirculation , insulin , diabetes mellitus , medicine , endocrinology , blood supply , chemistry , type 2 diabetes , peripheral , blood flow , biology , surgery
Substantial evidence suggests that RBCs contribute to matching of oxygen (O 2 ) supply with demand via release of small amounts of ATP in regions of increased O 2 need, enhancing blood flow appropriately. We simulated this system using a computational model incorporating network geometry and conducted signaling to predict microvascular flow responses to changes in tissue O 2 . To test this innovative model, we used Zucker Diabetic Fatty (ZDF) rats at 7 weeks (pre‐diabetes; high insulin, normal glucose) and at 12 weeks (type II diabetes [DMII]; normal insulin, high glucose). In pre‐diabetes, capillary O 2 supply was decreased without a decrease in capillary density. RBCs exposed to pre‐diabetic insulin levels (1 nM) did not release ATP in response to reduced O 2 and isolated arterioles perfused with insulin treated RBCs did not dilate in response to low extraluminal O 2 . Finally, RBCs of rats and humans with DMII did not release ATP when exposed to low O 2 and isolated arterioles perfused with RBCs of humans with DMII did not dilate in response to low O 2 . These findings in the intact microcirculation and isolated vessels are consistent with predictions of the computational model. This systems biology approach provides novel insights into the mechanisms by which O 2 supply is matched with O 2 demand and will enhance our understanding of the causes of peripheral vascular complications in pre‐ and type II diabetes. (NIH R33 HL089094 )

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom